161 related articles for article (PubMed ID: 36855009)
1. Detection of sympathetic denervation defects in Fabry disease by hybrid [
Gatterer C; Wollenweber T; Pichler V; Vraka C; Sunder-Plassmann G; Lenz M; Hengstenberg C; Hacker M; Loewe C; Graf S; Beitzke D
J Nucl Cardiol; 2023 Oct; 30(5):1810-1821. PubMed ID: 36855009
[TBL] [Abstract][Full Text] [Related]
2. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
[TBL] [Abstract][Full Text] [Related]
3. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
Augusto JB; Johner N; Shah D; Nordin S; Knott KD; Rosmini S; Lau C; Alfarih M; Hughes R; Seraphim A; Vijapurapu R; Bhuva A; Lin L; Ojrzyńska N; Geberhiwot T; Captur G; Ramaswami U; Steeds RP; Kozor R; Hughes D; Moon JC; Namdar M
Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):790-799. PubMed ID: 32514567
[TBL] [Abstract][Full Text] [Related]
4. Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction:
Aikawa T; Naya M; Obara M; Oyama-Manabe N; Manabe O; Magota K; Ito YM; Katoh C; Tamaki N
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1897-1905. PubMed ID: 28653180
[TBL] [Abstract][Full Text] [Related]
5. Clinical and CMR characteristics associated with cardiac events in patients with Fabry disease.
Hiestand R; Nowak A; Sokolska JM; Chan R; Ruschitzka F; Manka R; Gruner C
Int J Cardiol; 2023 Jul; 382():46-51. PubMed ID: 37044180
[TBL] [Abstract][Full Text] [Related]
6. Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients.
Nojiri A; Anan I; Morimoto S; Kawai M; Sakuma T; Kobayashi M; Kobayashi H; Ida H; Ohashi T; Eto Y; Shibata T; Yoshimura M; Hongo K
J Cardiol; 2020 Jan; 75(1):27-33. PubMed ID: 31623930
[TBL] [Abstract][Full Text] [Related]
7. Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.
Weidemann F; Beer M; Kralewski M; Siwy J; Kampmann C
Mol Genet Metab; 2019 Feb; 126(2):169-182. PubMed ID: 30594474
[TBL] [Abstract][Full Text] [Related]
8. 2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET.
Wong KK; Raffel DM; Bohnen NI; Altinok G; Gilman S; Frey KA
J Nucl Med; 2017 Feb; 58(2):326-331. PubMed ID: 27539837
[TBL] [Abstract][Full Text] [Related]
9. Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease.
Hanneman K; Karur GR; Wasim S; Wald RM; Iwanochko RM; Morel CF
Radiology; 2020 Jan; 294(1):42-49. PubMed ID: 31660802
[TBL] [Abstract][Full Text] [Related]
10. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.
Fallavollita JA; Heavey BM; Luisi AJ; Michalek SM; Baldwa S; Mashtare TL; Hutson AD; Dekemp RA; Haka MS; Sajjad M; Cimato TR; Curtis AB; Cain ME; Canty JM
J Am Coll Cardiol; 2014 Jan; 63(2):141-9. PubMed ID: 24076296
[TBL] [Abstract][Full Text] [Related]
11. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
Vijapurapu R; Nordin S; Baig S; Liu B; Rosmini S; Augusto J; Tchan M; Hughes DA; Geberhiwot T; Moon JC; Steeds RP; Kozor R
Heart; 2019 Mar; 105(6):470-476. PubMed ID: 30282640
[TBL] [Abstract][Full Text] [Related]
12. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography.
Stevens MJ; Raffel DM; Allman KC; Schwaiger M; Wieland DM
Metabolism; 1999 Jan; 48(1):92-101. PubMed ID: 9920151
[TBL] [Abstract][Full Text] [Related]
13. Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.
Wong KK; Raffel DM; Koeppe RA; Frey KA; Bohnen NI; Gilman S
Radiology; 2012 Oct; 265(1):240-7. PubMed ID: 22843766
[TBL] [Abstract][Full Text] [Related]
14. Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
Nordin S; Kozor R; Medina-Menacho K; Abdel-Gadir A; Baig S; Sado DM; Lobascio I; Murphy E; Lachmann RH; Mehta A; Edwards NC; Ramaswami U; Steeds RP; Hughes D; Moon JC
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1673-1683. PubMed ID: 29778854
[TBL] [Abstract][Full Text] [Related]
15. Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.
Spinelli L; Imbriaco M; Nappi C; Nicolai E; Giugliano G; Ponsiglione A; Diomiaiuti TC; Riccio E; Duro G; Pisani A; Trimarco B; Cuocolo A
Circ Cardiovasc Imaging; 2018 Apr; 11(4):e007019. PubMed ID: 29626078
[TBL] [Abstract][Full Text] [Related]
16. Quantification of myocardial deformation in patients with Fabry disease by cardiovascular magnetic resonance feature tracking imaging.
Zhao L; Zhang C; Tian J; Saiedi M; Ma C; Li N; Fang F; Ma X; Selvanayagam J
Cardiovasc Diagn Ther; 2021 Feb; 11(1):91-101. PubMed ID: 33708481
[TBL] [Abstract][Full Text] [Related]
17. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
18. Sympathetic denervation in patients with ischemic cardiomyopathy and risk on ventricular tachy-arrhythmias. A pilot study.
Noordzij W; Elvan A; Demirel F; Jager PL; Tio RA; Slart RH
Q J Nucl Med Mol Imaging; 2018 Dec; 62(4):429-435. PubMed ID: 27045577
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
20. Impact of presynaptic sympathetic imbalance in long-QT syndrome by positron emission tomography.
Zumhagen S; Vrachimis A; Stegger L; Kies P; Wenning C; Ernsting M; Müller J; Seebohm G; Paul M; Schäfers K; Stallmeyer B; Schäfers M; Schulze-Bahr E
Heart; 2018 Feb; 104(4):332-339. PubMed ID: 28864717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
